Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain

被引:186
作者
Proescholdt, MA
Heiss, JD
Walbridge, S
Mühlhauser, J
Capogrossi, MC
Oldfield, EH
Merrill, MJ
机构
[1] NINCDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA
[2] NIA, Cardiovasc Sci Lab, NIH, Baltimore, MD 21224 USA
[3] IRCC, Ist Dermopat Immacolatat, Lab Patol Vasc, Rome, Italy
关键词
adenovirus; blood-brain barrier; brain edema; inflammation; major histocompatibility complex; vascular permeability factor; VEGF;
D O I
10.1097/00005072-199906000-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Vascular endothelial growth factor (VEGF) is an angiogenic growth factor that also induces vascular permeability and macrophage migration. VEGF expression is weak in normal adult brain, but is strongly upregulated in glioma cells and reactive astrocytes, suggesting that chronic overexpression of VEGF in the brain contributes to blood-brain barrier (BBB) breakdown. We examined the effects of chronic VEGF overexposure on the integrity of the BBB using the following approaches: 1) continuous intracerebral infusion of VEGF via miniosmotic pump; and 2) intracerebral injection of an adenoviral vector encoding the VEGF(165) gene (AdCMV.VEGF). After 6 days both treatments produced similar to 10-fold breakdown of the BBB las measured by transport of C-14-aminoisobutyric acid (AIB) from blood into brain) compared with the respective controls (albumin infusion or AdCMV.beta gal virus). BBB disruption in AdCMV.VEGF-treated brains was accompanied by a severe inflammatory response not observed in brains receiving AdCMV.beta gal or VEGF protein infusion, indicating that neither VEGF nor viral particles alone were responsible for the inflammatory response. However, injection of AdCMV.beta gal followed by VEGF infusion to the same site also elicited inflammation. Chronic overexposure of normal brain to VEGF also increased intercellular adhesion molecule-1 (ICAM-1) and major histocompatibility complex (MHC) class I and II expression. Although VEGF itself is not inflammatory, VEGF may modulate immune responses in the central nervous system (CNS) by opening the BBB, altering the immunoprivileged status of the brain, and allowing contact between normally sequestered CNS antigens and blood-borne immune mediators.
引用
收藏
页码:613 / 627
页数:15
相关论文
共 65 条
[21]   THE FMS-LIKE TYROSINE KINASE, A RECEPTOR FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR [J].
DEVRIES, C ;
ESCOBEDO, JA ;
UENO, H ;
HOUCK, K ;
FERRARA, N ;
WILLIAMS, LT .
SCIENCE, 1992, 255 (5047) :989-991
[22]   DISTRIBUTION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IN TUMORS - CONCENTRATION IN TUMOR BLOOD-VESSELS [J].
DVORAK, HF ;
SIOUSSAT, TM ;
BROWN, LF ;
BERSE, B ;
NAGY, JA ;
SOTREL, A ;
MANSEAU, EJ ;
VANDEWATER, L ;
SENGER, DR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (05) :1275-1278
[23]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[24]  
Folkman J, 1992, INFLAMMATION BASIC P, P821
[25]   GLIOBLASTOMA EXPRESSION OF VITRONECTIN AND THE ALPHA-V-BETA-3 INTEGRIN - ADHESION MECHANISM FOR TRANSFORMED GLIAL-CELLS [J].
GLADSON, CL ;
CHERESH, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1924-1932
[26]   CNS ANTIGEN PRESENTATION [J].
HART, MN ;
FABRY, Z .
TRENDS IN NEUROSCIENCES, 1995, 18 (11) :475-481
[27]   Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats - Involvement of the glucocorticoid receptor and vascular permeability factor [J].
Heiss, JD ;
Papavassiliou, E ;
Merrill, MJ ;
Nieman, L ;
Knightly, JJ ;
Walbridge, S ;
Edwards, NA ;
Oldfield, EH .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (06) :1400-1408
[28]   Clinical evidence of angiogenesis after arterial gene transfer of phVEGF(165) in patient with ischaemic limb [J].
Isner, JM ;
Pieczek, A ;
Schainfeld, R ;
Blair, R ;
Haley, L ;
Asahara, T ;
Rosenfield, K ;
Razvi, S ;
Walsh, E ;
Symes, JF .
LANCET, 1996, 348 (9024) :370-374
[29]  
JOHNSON RT, 1994, ANN NEUROL S, V36, P54
[30]  
Kaya M., 1996, Society for Neuroscience Abstracts, V22, P53